Metropolis Healthcare Ltd - 542650 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, please find enclosed herewith, Disclosure of Related Party Transactions for the half year ended March 31, 2023. Kindly take the same on record. Metropolis Healthcare Ltd - 542650 - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, May 16, 2023
The Board of Directors of the Company at their Meeting held today i.e. Tuesday, May 16 2023 have inter- alia approved i. Re-appointment of M/s. Suresh Surana & Associates LLP, Chartered Accountants, as the Internal Auditors of the Company for the financial year 2023-24. ii. Re-appointment of M/s. Joshi Apte & Associates, as the Cost auditor of the Company for the financial year 2023-24. iii. Re-appointment of M/s. Manish Ghia & Associates as the Secretarial Auditors of the Company for the financial year 2023-24. iv. Re-appointment of Mr. Sanjay Bhatnagar (DIN: 00867848) and Mr. Vivek Gambhir (DIN: 06527810) as Non-Executive Independent Directors for a second term of 5 years, subject to the approval of shareholders of the Company. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith is the Press Release as mentioned below: 'Metropolis' Core-Revenue Growth (Excl. Covid & Covid Allied, PPP Contract & Hi-Tech) at Rs. 245 crs in Q4FY23; up by 15% YoY' You are requested to take the above information on record. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copy of Investor Presentation for the quarter ended March 31, 2023. You are requested to take the above information on record. Metropolis Healthcare Ltd - 542650 - Audited Financial Results (Standalone And Consolidated) For Quarter And Financial Year Ended March 31, 2023
This is to inform you that the Board of Directors of the Company at their Meeting held today i.e. Tuesday, May 16, 2023 have inter-alia: Approved the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2023, and noted the Statutory Audit Report issued by the Statutory Auditors of the Company thereon. The Copy of the Audited Standalone & Consolidated Financial Statement of the Company together with the Statutory Audit Report thereon for the financial year ended March 31, 2023 as approved by the Board of Directors is enclosed herewith as Annexure - 1 The meeting commenced at 03:00 p.m. (IST) and concluded at 06:05 p.m. (IST) Metropolis Healthcare Ltd - 542650 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Metropolis Healthcare Ltd 2 CIN NO. L73100MH2000PLC192798 3 Report filed for FY 2022-2023 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2022-23 & 2023-24 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) NA 8Quantum of (d), which has been met from (c)(e)* NA 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* NA Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)NA Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Neha ShahDesignation :-Interim Compliance Officer Name of the Chief Financial Officer :- Rakesh Agarwal Designation : -Chief Financial Officer Date: 15/05/2023 Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('SEBI Listing Regulations'), we would like to inform you that the Company will participate in the Q4FY23 Earnings Conference Call (i.e. Post Earnings/Quarterly Call), as organized by Axis Capital Limited on Wednesday, May 17, 2023 at 9:00 a.m. (IST) to discuss the financial results of the Company for the quarter ended March 31, 2023 as per details enclosed herewith. Metropolis Healthcare Ltd - 542650 - Board Meeting Intimation for Notice Of Board Meeting Scheduled To Be Held On Tuesday, May 16, 2023
Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2023 ,inter alia, to consider and approve We wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, May 16, 2023, to inter alia, consider and approve the Audited Standalone & Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2023. Further, we also wish to inform you that in terms of the Company's Code of Fair Disclosure of Unpublished Price Sensitive Information, the Trading Window for dealing in the securities of the Company has been closed for the Designated Persons of the Company and their immediate relatives with effect from April 01, 2023 and shall reopen 48 hours after the declaration of the Financial Results of the Company for the quarter and financial year ended March 31, 2023, as intimated to the stock exchanges vide its letter MHL/Sec&Legal/2022-23/98 dated March 30, 2023. Metropolis Healthcare Ltd - 542650 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2023
Pursuant to the requirements of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed herewith the Compliance Certificate for the financial year ended March 31, 2023, duly signed by the Interim Compliance Officer of Metropolis Healthcare Limited ('the Company') and the Authorized Representative of Link Intime India Private Limited, the Registrar and Share Transfer Agent of the Company.